Novo CEO pressed by Senate to chop prices of obesity, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would take into account new talks with insurers with regard to the list charges of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. https://titusikjjj.liberty-blog.com/30740770/the-smart-trick-of-healthcare-news-that-nobody-is-discussing